Latest News & Updates of Loncom Pharma

Breaking Medical News: Sorafenib Tosylate Shows Promise in Advancing Cancer TreatmentIn a significant development in the field of oncology, a recent study has unveiled promising results for Sorafenib Tosylate, a tyrosine kinase inhibitor commonly used in the treatment of advanced liver and kidney ca

On the morning of May 21, 2021, the special day of Shandong Loncom Pharmaceutical Co.,Ltd.'s 9th anniversary, the group leaders and all employees of Shandong Loncom Pharmaceutical Co.,Ltd. participate in the flag raising ceremony together to celebrate the 9th anniversary of establishment of Shandong

On April 15, 2022, the National Drug Administration approves the production and listing of Lacosamide Oral Solution (National Drug Approval Number H20223222), which lets Shandong Loncom Pharmaceutical Co.,Ltd. be the first successful imitation enterprise on this product in China.Lacosamide Oral Solu

In order to learn, promote, and implement GMP and regulations better, stimulate employees' enthusiasm for learning, enhance their quality awareness, and improve the quality management level of the enterprise, the Quality Management Department organizes the "2022 GMP and Regulatory Knowledge Competit